These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A Review of the use of Flumazenil for the Reversal of Midazolam Conscious Sedation in Dentistry.
    Author: Folland L, Brown E, Boyle C.
    Journal: SAAD Dig; 2017 Jan; 33():13-7. PubMed ID: 29616542.
    Abstract:
    The practice of midazolam conscious sedation is well established in dentistry. The drug flumazenil is a specific benzodiazepine antagonist and is an essential requirement in settings where midazolam is used. A literature review has been carried out, examining the available information regarding flumazenil’s safety, administration, potential complications and the regulatory documentation which governs its use. Flumazenil is a safe drug to use for the reversal of midazolam induced conscious sedation although the evidence surrounding its use is limited.
    [Abstract] [Full Text] [Related] [New Search]